Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells

Infection and Immunity

Volumn 73, Issue 12, 2005, Pages 7967-7976

  Tada, Hiroyuki ^a   Aiba, Setsuya ^b   Shibata, Ken Ichiro ^c   Ohteki, Toshiaki ^d   Takada, Haruhiko ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

[2,3 BIS(PALMITOYLOXY)PROPYL] N PALMITOYLPENTAPEPTIDE; ADJUVANT; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; DNA; GAMMA INTERFERON; GLUDAPCIN; HEPTANOYL GAMMA DEXTRO GLUTAMYL 2,6 DIAMINOPIMELOYL DEXTRO ALANINE; IMMUNOMODULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; LIPID A; LIPOPEPTIDE; MURAMYL DIPEPTIDE; NOD1 AGONIST; NOD2 AGONIST; PEPTIDOGLYCAN; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN NOD1; PROTEIN P70; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 3 AGONIST; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR 9 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CELL LINEAGE; CELL STIMULATION; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DRUG POTENTIATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERFERON PRODUCTION; MONOCYTE; PRIORITY JOURNAL; SUPERNATANT; TH1 CELL;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADJUVANTS, IMMUNOLOGIC; CYTOKINES; DENDRITIC CELLS; DIAMINOPIMELIC ACID; DRUG SYNERGISM; HUMANS; INTERLEUKIN-12; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID A; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; OLIGODEOXYRIBONUCLEOTIDES; OLIGOPEPTIDES; POLY I-C; POLYLYSINE; RNA, MESSENGER; TH1 CELLS; TOLL-LIKE RECEPTORS;

EID: 28444471235     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.12.7967-7976.2005     Document Type: Article

References (51)

1. Adam, A. 1985. Synthetic adjuvants. John Wiley & Sons, New York, N.Y.
2. Agrawal, S., A. Agrawal, B. Doughty, A. Gerwitz, J. Blenis, T. Van Dyke, and B. Pulendran. 2003. Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 171:4984-4989.
3. Askew, D., R. S. Chu, A. M. Krieg, and C. V. Harding. 2000. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. J. Immunol. 165:6889-6895.
4. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
5. Bessler, W. G., R. B. Johnson, K. Wiesmüller, and G. Jung. 1982. B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein. Hoppe-Seyler's Z. Physiol. Chem. 363:767-770.
6. Bradley, L. M., D. K. Dalton, and M. Croft. 1996. A direct role for IFN-γ in regulation of Th1 cell development. J. Immunol. 157:1350-1358.
7. Chamaillard, M., M. Hashimoto, Y. Horie, J. Masumoto, S. Qiu, L. Saab, Y. Ogura, A. Kawasaki, K. Fukase, S. Kusumoto, M. A. Valvano, S. J. Foster, T. W. Mak, G. Nuñez, and N. Inohara. 2003. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4:702-707.
8. Ellouz, F., A. Adam, R. Ciorbaru, and E. Lederer. 1974. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59:1317-1325.
9. Fleck, J., M. Mock, F. Tytgat, C. Nauciel, and R. Minck. 1974. Adjuvant activity in delayed hypersensitivity of the peptidic part of bacterial peptidoglycans. Nature 250:517-518.
10. Freund, J., and K. McDermott. 1942. Sensitization to horse serum by means of adjuvants. Proc. Soc. Exp. Biol. Med. 49:548-553.
11. Girardin, S. E., I. G. Boneca, L. A. M. Carneiro, A. Antignac, M. Jéhanno, J. Viala, K. Tedin, M.-K. Taha, A. Labigne, U. Zähringer, A. J. Coyle, P. S. DiStefano, J. Bertin, P. J. Sansonetti, and D. J. Philpott. 2003. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584-1587.
12. Girardin, S. E., I. G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, D. J. Philpott, and P. J. Sansonetti. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:8869-8872.
13. Goto, T., and H. Aoki. 1987. The immunomodulatory activities of acylpeptides, p. 99-108. In I. Azuma and G. Jollès (ed.), Immunostimulants: now and tomorrow. Japan Science Society Press, Tokyo, Japan.
14. Grumont, R., H. Hochrein, M. O'Keeffe, R. Gugasyan, C. White, I. Caminschi, W. Cook, and S. Gerondakis. 2001. c-Rel regulates interleukin 12 p70 expression in CD8+ dendritic cells by specifically inducing p35 gene transcription. J. Exp. Med. 194:1021-1031.
15. Gutierrez, O., C. Pipaon, N. Inohara, A. Fontalba, Y. Ogura, F. Prosper, G. Nuñez, and J. L. Fernandez-Luna. 2002. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation. J. Biol. Chem. 277:41701-41705.
16. Inohara, N., Y. Ogura, F. F. Chen, A. Muto, and G. Nuñez. 2001. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276:2551-2554.
17. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, S. J. Foster, A. P. Moran, J. L. Fernandez-Luna, and G. Nuñez. 2003. Host recognition of bacterial muramyl dipeptide mediated through Nod2: implications for Crohn's disease. J. Biol. Chem. 278:5509-5512.
18. Ito, T., R. Amakawa, M. Inaba, S. Ikehara, K. Inaba, and S. Fukuhara. 2001. Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166:2961-2969.
19. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987-995.
20. Kaisho, T., and S. Akira. 2003. Regulation of dendritic cell function through Toll-like receptors. Curr. Mol. Med. 3:373-385.
21. Kalinski, P., J. H. N. Schuitemaker, C. M. U. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-γ and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 162:3231-3236.
22. Kitaura, Y., H. Takeno, M. Aratani, S. Okada, S. Yonishi, K. Hemmi, O. Nakaguchi, and M. Hashimoto. 1982. Synthesis and RES-stimulating activity of bacterial cell-wall peptidoglycan peptides related to FK-156. Experientia 38:1101-1103.
23. Koski, G. K., K. Karikó, S. Xu, D. Weissman, P. A. Cohen, and B. J. Czerniecki. 2004. Innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J. Immunol. 172:3989-3993.
24. Kotani, S., Y. Watanabe, F. Kinoshita, T. Shimono, I. Morisaki, T. Shiba, S. Kusumoto, Y. Tarumi, and K. Ikenaka. 1975. Immunoadjuvant activities of synthetic N-acetylmuramyl-peptides or -amino acids. Biken J. 18:105-111.
25. + T cells. J. Immunol. 154:5071-5079.
26. Mosca, P. J., A. C. Hobeika, T. M. Clay, S. K. Nair, E. K. Thomas, M. A. Morse, and H. K. Lyerly. 2000. A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-γ treatment. Blood 96:3499-3504.
27. Nagayama, H., K. Sato, H. Kawasaki, M. Enomoto, C. Morimoto, K. Tadokoro, T. Juji, S. Asano, and T. A. Takahashi. 2000. IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells. J. Immunol. 165:59-66.
28. Nakahira, M., H.-J. Ahn, W.-R. Park, P. Gao, M. Tomura, C.-S. Park, T. Hamaoka, T. Ohta, M. Kurimoto, and H. Fujiwara. 2002. Synergy of IL-12 and IL-18 for IFN-γ gene expression: IL-12-induced STAT4 contributes to IFN-7 promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J. Immunol. 168:1146-1153.
29. Nakamura, J., K. Shibata, A. Hasebe, T. Into, T. Watanabe, and N. Ohata. 2002. Signaling pathways induced by lipoproteins derived from Mycoplasma salivarium and a synthetic lipopeptide (FSL-1) in normal human gingival fibroblasts. Microbiol. Immunol. 46:151-158.
30. + T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12/IL-4 stimulation in vitro. Eur. J. Immunol. 32:341-347.
31. Re, F., and J. L. Strominger. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276:37692-37699.
32. Re, F., and J. L. Strominger. 2004. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J. Immunol. 173:7548-7555.
33. Redecke, V., H. Häcker, S. K. Datta, A. Fermin, P. M. Pitha, D. H. Broide, and E. Raz. 2004. Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172:2739-2743.
34. Schleifer, K. H., and O. Kandler. 1972. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36:407-477.
35. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406-17409.
36. Snijders, A., P. Kalinski, C. M. U. Hilkens, and M. L. Kapsenberg. 1998. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10:1593-1598.
37. Stewart-Tull, D. E. S. 1985. Immunopotentiating activity of peptidoglycan and surface polymers, p. 47-89. In D. E. S. Stewart-Tull and M. Davis (ed.), Immunology of the bacterial cell envelope. John Wiley & Sons, Chichester, United Kingdom.
38. Stoll, S., H. Jonuleit, E. Schmitt, G. Müller, H. Yamauchi, M. Kurimoto, J. Knop, and A. H. Enk. 1998. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur. J. Immunol. 28:3231-3239.
39. Takada, H., and S. Kotani. 1985. Immunopharmacological activities of synthetic muramyl-peptides, p. 119-152. In D. E. S. Stewart-Tull and M. Davies (ed.), Immunology of the bacterial cell envelope. John Wiley & Sons, Chichester, United Kingdom.
40. Takada, H., and S. Kotani. 1995. Muramyl dipeptide and derivatives, p. 171-202. In D. E. S. Stewart-Tull (ed.), The theory and practical application of adjuvants. John Wiley & Sons, Chichester, United Kingdom.
41. Takada, H., S. Yokoyama, and S. Yang. 2002. Enhancement of endotoxin activity by muramyldipeptide. J. Endotoxin Res. 8:337-342.
42. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451.
43. Trinchieri, G. 1993. Interleukin-12 and its role in the regulation of Th1 cells. Immunol. Today 14:335-338.
44. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
45. Uehara, A., S. Yang, Y. Fujimoto, K. Fukase, S. Kusumoto, K. Shibata, S. Sugawara, and H. Takada. 2005. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 7:53-61.
46. Vidal, V. F., N. Castéran, C. J. Riendeau, H. Kornfeld, E. C. A. Darcissac, A. Capron, and G. M. Bahr. 2001. Macrophage stimulation with murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPβ and STAT1: role of CD14 and Toll-like receptor 2 and 4. Eur. J. Immunol. 31:1962-1971.
47. Watanabe, T., A. Kitani, P. J. Murray, and W. Strober. 2004. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5:800-808.
48. Wiesmüller, K.-H., W. Bessler, and G. Jung. 1983. Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein. Hoppe Seyler's Z. Physiol. Chem. 364:593-606.
49. Wolfert, M. A., T. F. Murray, G.-J. Boons, and J. N. Moore. 2002. The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J. Biol. Chem. 277:39179-39186.
50. Yang, S., R. Tamai, S. Akashi, O. Takeuchi, S. Akira, S. Sugawara, and H. Takada. 2001. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 69:2045-2053.
51. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1-5.